HK1213051A1 - 用於預測和監測粘膜愈合的方法 - Google Patents

用於預測和監測粘膜愈合的方法

Info

Publication number
HK1213051A1
HK1213051A1 HK16100852.9A HK16100852A HK1213051A1 HK 1213051 A1 HK1213051 A1 HK 1213051A1 HK 16100852 A HK16100852 A HK 16100852A HK 1213051 A1 HK1213051 A1 HK 1213051A1
Authority
HK
Hong Kong
Prior art keywords
predicting
methods
mucosal healing
monitoring mucosal
monitoring
Prior art date
Application number
HK16100852.9A
Other languages
English (en)
Inventor
Sharat Singh
Xinjun Liu
Scott Hauenstein
Richard Kirkland
Katherine Drake
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of HK1213051A1 publication Critical patent/HK1213051A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
HK16100852.9A 2012-10-05 2016-01-26 用於預測和監測粘膜愈合的方法 HK1213051A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261710491P 2012-10-05 2012-10-05
US201361824959P 2013-05-17 2013-05-17
PCT/IB2013/059077 WO2014054013A1 (en) 2012-10-05 2013-10-02 Methods for predicting and monitoring mucosal healing

Publications (1)

Publication Number Publication Date
HK1213051A1 true HK1213051A1 (zh) 2016-06-24

Family

ID=49447587

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16100852.9A HK1213051A1 (zh) 2012-10-05 2016-01-26 用於預測和監測粘膜愈合的方法

Country Status (11)

Country Link
US (1) US20150355195A1 (zh)
EP (3) EP2904405B1 (zh)
JP (1) JP2015532425A (zh)
CN (1) CN104838270A (zh)
AU (2) AU2013326070A1 (zh)
CA (1) CA2887035A1 (zh)
ES (2) ES2771127T3 (zh)
HK (1) HK1213051A1 (zh)
MX (1) MX358730B (zh)
SG (1) SG11201502646RA (zh)
WO (1) WO2014054013A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG194710A1 (en) 2011-05-10 2013-12-30 Nestec Sa Methods of disease activity profiling for personalized therapy management
WO2016063223A1 (en) * 2014-10-20 2016-04-28 Nestec S.A. Methods for predicting clinical outcomes in subjects afflicted with ulcerative colitis
US20170258820A1 (en) 2014-10-29 2017-09-14 Glycom A/S Synthetic composition and method for promoting mucosal healing
GB201501612D0 (en) * 2015-01-30 2015-03-18 Univ Birmingham Assay
GB201611738D0 (en) 2016-07-05 2016-08-17 Cambridge Entpr Ltd Biomarkers for inflammatory bowel disease
JP2020523560A (ja) * 2017-05-31 2020-08-06 プロメテウス バイオサイエンシーズ インコーポレイテッド クローン病患者の粘膜治癒を評価する方法
CN110646620A (zh) * 2019-09-29 2020-01-03 湖北新纵科病毒疾病工程技术有限公司 一种同时检测四项炎症标志物的方法及其试剂盒
CN111477325A (zh) * 2020-04-09 2020-07-31 赣南师范大学 基于粒子群优化算法对引发肠道溃疡疾病进行鉴别的方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0615129T3 (da) 1993-03-10 2000-08-07 Cedars Sinai Medical Center Fremgangsmåder til selektiv påvisning af perinukleært anti-neutrophilt cytoplasmatisk antistof fra ulcerativ colitis eller
US5830675A (en) 1993-03-10 1998-11-03 Cedars-Sinai Medical Center Methods for selectively detecting perinuclear anti-neutrophil cytoplasmic antibody of ulcerative colitis, primary sclerosing cholangitis, or type 1 autoimmune hepatitis
US6218129B1 (en) 1998-05-15 2001-04-17 Prometheus Laboratories, Inc. Inflammatory bowel disease first step assay system
US6406862B1 (en) 1998-10-06 2002-06-18 The United States Of America As Represented By The Secretary Of The Army Dip-stick assay for C-reactive protein
FR2802536B1 (fr) 1999-11-23 2003-06-13 Chru Lille Oligomannosides de synthese, leur preparation et leur utilisation a la detection d'anticorps et a la prevention d'infections
US6838250B2 (en) 2000-03-31 2005-01-04 Ortho-Clinical Diagnostics, Inc. Immunoassay for C-reactive protein
WO2001081404A2 (en) * 2000-04-20 2001-11-01 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services INDUCIBLE PLASMID VECTOR ENCODING TGF-β AND USES THEREOF
US7138237B1 (en) 2000-05-19 2006-11-21 Cedars-Sinai Medical Center Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen
AU2002365279B2 (en) 2001-12-17 2009-08-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
US20040197304A1 (en) * 2003-04-01 2004-10-07 The Procter & Gamble Company And Alimentary Health, Ltd. Methods of determining efficacy of treatments of inflammatory diseases of the bowel
WO2005041896A2 (en) 2003-11-03 2005-05-12 Duke University Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke
WO2006012472A1 (en) 2004-07-21 2006-02-02 Qualyst, Inc. Apparatus, kits and methods for evaluating binding interactions, for detecting and quantifying binding molecules, and for sample preparation
WO2007087576A2 (en) 2006-01-24 2007-08-02 The Uab Research Foundation Compositions and methods for the identification and treatment of immune-mediated inflammatory diseases
MX2009003048A (es) 2006-09-21 2009-09-07 Prometheus Lab Inc Disposiciones a base de anticuerpo para detectar transductores de multiple señal en celulas circulantes raras.
KR101553723B1 (ko) 2007-07-13 2015-09-16 네스텍 소시에테아노님 항체­기반 어레이를 사용한 폐 암 치료를 위한 약물 선별법
ES2545760T3 (es) 2008-02-25 2015-09-15 Nestec S.A. Selección de fármacos para terapia del cáncer de mama utilizando matrices de anticuerpos
CN101780269A (zh) * 2009-01-21 2010-07-21 北京三有利科技发展有限公司 细胞生长因子治疗溃疡性疾病和肺纤维化疾病的应用
CA2761777A1 (en) 2009-05-14 2010-11-18 Prometheus Laboratories Inc. Biomarkers for determining sensitivity of breast cancer cells to her2-targeted therapy
AU2010273319B2 (en) 2009-07-15 2015-01-22 Nestec S.A. Drug selection for gastric cancer therapy using antibody-based arrays
CA2777934A1 (en) 2009-10-20 2011-04-28 Prometheus Laboratories Inc. Proximity-mediated assays for detecting oncogenic fusion proteins
RU2571489C2 (ru) 2009-10-26 2015-12-20 Нестек С.А. Способы выявления препаратов и аутоантител против tnf
CA2781654A1 (en) * 2009-11-25 2011-06-03 Hua Gong Novel genomic biomarkers for irritable bowel syndrome diagnosis
CA2801575A1 (en) * 2010-06-04 2011-12-08 Prometheus Laboratories Inc. Methods for improving inflammatory bowel disease diagnosis
BR112013009376A2 (pt) 2010-10-18 2016-07-26 Nestec Sa métodos para determinar isótipos de anticorpos antifármacos
CA2822283A1 (en) 2010-12-23 2012-06-28 Nestec S.A. Drug selection for malignant cancer therapy using antibody-based arrays
BR112013020981A2 (pt) 2011-02-17 2016-10-11 Nestec Sa ensaios para a detecção de auto-anticorpos para os fármacos anti-tnf<244>
EP2681552A2 (en) 2011-03-02 2014-01-08 Nestec S.A. Prediction of drug sensitivity of lung tumors based on molecular and genetic signatures
MX343324B (es) 2011-07-06 2016-11-01 Nestec Sa Ensayos para detectar auto anticuerpos neutralizadores de la terapia biologica con tnf alpha.
WO2013033623A1 (en) 2011-09-02 2013-03-07 Nestec S.A. Profiling of signal pathway proteins to determine therapeutic efficacy

Also Published As

Publication number Publication date
EP2904405B1 (en) 2017-05-31
US20150355195A1 (en) 2015-12-10
MX2015004272A (es) 2015-08-14
EP3217179B9 (en) 2020-06-10
CA2887035A1 (en) 2014-04-10
MX358730B (es) 2018-09-03
EP3217179A1 (en) 2017-09-13
EP2904405A1 (en) 2015-08-12
AU2013326070A1 (en) 2015-04-23
CN104838270A (zh) 2015-08-12
ES2771127T3 (es) 2020-07-06
EP3217179B1 (en) 2020-01-08
WO2014054013A1 (en) 2014-04-10
SG11201502646RA (en) 2015-05-28
AU2019204276A1 (en) 2019-07-04
JP2015532425A (ja) 2015-11-09
EP3640645A1 (en) 2020-04-22
ES2638971T3 (es) 2017-10-24

Similar Documents

Publication Publication Date Title
GB2518060B (en) Position monitoring system and method
GB2508314B (en) Structure monitoring
EP2906697A4 (en) METHODS OF MONITORING C9ORF72 EXPRESSION
GB201214976D0 (en) Monitoring system
EP2911438A4 (en) METHOD AND DEVICE FOR MONITORING
EP2913601A4 (en) MONITORING SYSTEM
EP2876622A4 (en) DEVICE FOR MONITORING THE ENVIRONMENT OF A VEHICLE DEVICE AND SYSTEM FOR MONITORING THE ENVIRONMENT OF A VEHICLE
EP2775918A4 (en) DEVICE AND METHODS FOR CONTROLLING SUBSTANCE TO BE ANALYZED
GB201215649D0 (en) System monitoring
HK1213051A1 (zh) 用於預測和監測粘膜愈合的方法
EP2936952A4 (en) UNIT AND METHOD OF COOLING
PL2817815T3 (pl) System monitorowania wilgolności
EP2834796A4 (en) MONITORING SYSTEM
EP2900833A4 (en) REAL-TIME MONITORING
EP2699175A4 (en) ANALYTICAL MONITORING DEVICES AND METHODS
EP2937807A4 (en) MONITORING DEVICE AND METHOD
AP3892A (en) Method and device for continuous dry methanisation
HUP1100486A2 (en) Monitoring system and method
EP2929517A4 (en) MONITORING SYSTEM AND METHOD
EP2801081A4 (en) MONITORING OF AN OBJECT
LT2828926T (lt) Stebėsenos aparatas
GB2496402B (en) Monitoring apparatus
GB201204789D0 (en) System monitoring
EP2814393A4 (en) COMPOSITIONS AND METHODS FOR MONITORING BIOMETRIC INDICATORS
GB2500000B (en) Microwave monitoring